Drug Trial Radar · NCT04683848
Study to Assess the Efficacy and Safety of MT-3921 in Subjects With Acute Traumatic Cervical Spinal Cord Injury
Last checked: Nov 20, 2026Latest source record: Dec 16, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
72
Actual
Start
Aug 27, 2021
Primary completion
Dec 24, 2024
Study completion Apr 9, 2025
Sponsor
- Lead sponsor
- Tanabe Pharma America, Inc.Industry
- Sponsor type
- Industry
- First posted
- Dec 24, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the efficacy and safety of intravenous (IV) infusions of MT-3921 to placebo in subjects with acute traumatic cervical spinal cord injury. Subjects meeting eligibility criteria will enter the 6-month double-blind period. Subjects will be randomized in a 2:1 ratio to receive MT-3921 or placebo in a double blind manner.
Conditions
- Spinal Cord Injury
Interventions
MT-3921Biological
Solution for infusion; Intravenous (IV)
PlaceboBiological
Solution for infusion; Intravenous (IV)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Upper Extremity Motor Score (UEMS)Time frame: Baseline and at Day 180
Locations
23 sites in 3 countries. Site status is shown where the registry gives one.
University of California Irvine
Orange, California
Tallahassee Neurological Clinic
Tallahassee, Florida
Augusta University
Augusta, Georgia
University of Kentucky
Lexington, Kentucky
Spectrum Health
Grand Rapids, Michigan
University of Mississippi Medical Center
Jackson, Mississippi
Saint Louis University Hospital
St Louis, Missouri
University of Nebraska Medical Center
Omaha, Nebraska
Carolinas Rehabilitation
Charlotte, North Carolina
University of Cincinnati
Cincinnati, Ohio
Oregon Health and Science University - Center for Health & Healing
Portland, Oregon
Brooke Army Medical Center in San Antonio
Houston, Texas
The University of Texas Health Science Center at San Antonio
San Antonio, Texas
Carilion Clinic
Roanoke, Virginia
Medical College of Wisconsin - Froedtert Hospital
Milwaukee, Wisconsin
NSHA-Queen Elizabeth II Health Sciences Centre
Halifax, Nova Scotia, Canada
The Ottawa Hospital
Ottawa, Ontario, Canada
Japan Organization of Occupational Health and Safety SPINAL INJURIES CENTER
Izuka-shi, Fukuoka, Japan
Gifu University Hospital
Gifu, Gifu, Japan
Hokkaido Spinal Cord Injury Center
Bibai-shi, Hokkaido, Japan
Japanese Red Cross Kobe Hospital
Kobe, Hyōgo, Japan
National Hospital Organization Kumamoto Medical Center
Kumamoto, Kumamoto, Japan
Murayama Medical Center
Musashimurayama-shi, Tokyo, Japan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.